Nord/LB set a €110.00 ($129.41) target price on Bayer AG (FRA:BAYN) in a research report released on Friday. The firm currently has a neutral rating on the healthcare company’s stock.

A number of other equities analysts have also recently commented on BAYN. UBS AG set a €125.00 ($147.06) target price on Bayer AG and gave the company a buy rating in a report on Tuesday, June 27th. J P Morgan Chase & Co restated a buy rating on shares of Bayer AG in a report on Friday. Commerzbank Ag set a €124.00 ($145.88) target price on Bayer AG and gave the company a buy rating in a report on Friday. Citigroup Inc. set a €130.00 ($152.94) target price on Bayer AG and gave the company a buy rating in a report on Thursday, October 5th. Finally, Sanford C. Bernstein set a €129.00 ($151.76) target price on Bayer AG and gave the company a buy rating in a report on Friday. Eight research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of €121.86 ($143.37).

Shares of Bayer AG (BAYN) opened at 118.15 on Friday. Bayer AG has a 12-month low of €85.72 and a 12-month high of €123.82. The company has a market capitalization of €103.04 billion and a P/E ratio of 20.44. The company has a 50 day moving average price of €111.66 and a 200 day moving average price of €112.26.

ILLEGAL ACTIVITY NOTICE: “Nord/LB Reiterates “€110.00” Price Target for Bayer AG (BAYN)” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/10/15/nordlb-reiterates-110-00-price-target-for-bayer-ag-bayn.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.